Pacific Biosciences Of California (PACB) Current Assets (2010 - 2026)

Pacific Biosciences Of California has reported Current Assets for 17 years, with the latest figure at $338.6 million in Q2 2026.

• On a quarterly basis, Current Assets fell 18.08% year-over-year to $338.6 million in Q2 2026; TTM through Jun 2026 was $338.6 million, a 18.08% decrease from a year earlier, with the FY2025 full-year figure at $375.1 million, down 24.34% from the prior year.
• Current Assets was $338.6 million for Q2 2026 at Pacific Biosciences Of California, down from $369.5 million in the prior quarter.
• The five-year high for Current Assets was $1.0 billion in Q1 2022, with the low at $338.6 million in Q2 2026.
• Average Current Assets over 5 years is $668.2 million, with a median of $652.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Current Assets decreased 3.46% in 2023, then sank 34.28% in 2025.
• Over 5 years, Current Assets stood at $852.1 million in 2022, then retreated by 12.91% to $742.0 million in 2023, then slumped by 33.2% to $495.7 million in 2024, then dropped by 24.34% to $375.1 million in 2025, then declined by 9.71% to $338.6 million in 2026.
• The last three Current Assets figures came in at $338.6 million (Q2 2026), $369.5 million (Q1 2026), and $375.1 million (Q4 2025), per Business Quant data.